- Home
- RLYB vs LEE Comparison
RLYB vs LEE Comparison
Compare RLYB & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- LEE
- Stock Information
- Founded
- RLYB 2018
- LEE 1890
- Country
- RLYB United States
- LEE United States
- Employees
- RLYB N/A
- LEE N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- LEE Newspapers/Magazines
- Sector
- RLYB Health Care
- LEE Consumer Discretionary
- Exchange
- RLYB Nasdaq
- LEE Nasdaq
- Market Cap
- RLYB 45.2M
- LEE N/A
- IPO Year
- RLYB 2021
- LEE N/A
- Fundamental
- Price
- RLYB $0.95
- LEE $15.15
- Analyst Decision
- RLYB Buy
- LEE
- Analyst Count
- RLYB 6
- LEE 0
- Target Price
- RLYB $8.10
- LEE N/A
- AVG Volume (30 Days)
- RLYB 106.4K
- LEE 25.7K
- Earning Date
- RLYB 11-07-2024
- LEE 12-12-2024
- Dividend Yield
- RLYB N/A
- LEE N/A
- EPS Growth
- RLYB N/A
- LEE N/A
- EPS
- RLYB N/A
- LEE N/A
- Revenue
- RLYB $598,000.00
- LEE $611,380,000.00
- Revenue This Year
- RLYB N/A
- LEE $2.04
- Revenue Next Year
- RLYB N/A
- LEE N/A
- P/E Ratio
- RLYB N/A
- LEE N/A
- Revenue Growth
- RLYB N/A
- LEE N/A
- 52 Week Low
- RLYB $0.93
- LEE $7.56
- 52 Week High
- RLYB $3.46
- LEE $19.63
- Technical
- Relative Strength Index (RSI)
- RLYB 37.53
- LEE 41.55
- Support Level
- RLYB $0.93
- LEE $14.52
- Resistance Level
- RLYB $1.24
- LEE $15.99
- Average True Range (ATR)
- RLYB 0.08
- LEE 1.04
- MACD
- RLYB -0.02
- LEE -0.21
- Stochastic Oscillator
- RLYB 6.45
- LEE 41.21
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.